Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Laparotomy, Laparoscopy, da Vinci System
Completed clinical trial evaluating laparotomy, laparoscopy, and robotic da Vinci System approaches for stomach and pancreatic neoplasms, as…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma [Phase 2]
A Phase II neoadjuvant trial evaluating tislelizumab with radiotherapy and gemcitabine/cisplatin chemotherapy for borderline/unresectable hi…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers [Phase 2]
Phase 2 clinical trial update for Tripegfilgrastim to reduce severe neutropenia in patients with unresectable pancreatic cancer and unresect…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is investigating sequential anti-angiogenic therapy after immunotherapy in advanced biliary tract cancers, includin…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Bile Omics for Diagnosing Indeterminate Biliary Strictures
A recruiting study evaluating Bile Omics as a diagnostic tool for indeterminate biliary strictures to improve detection of biliary cancers a…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations [Phase 2]
Phase 2 trial update on Infigratinib for FGFR-mutant advanced or metastatic solid tumors, including cholangiocarcinoma. Results posted 2025-…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating LSTA1 in combination with standard of care versus standard of care alone for patients with advanced cholangiocarcin…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]
Phase 2 clinical study evaluating the efficacy and safety of paclitaxel polymeric micelles for injection in patients with taxane-resistant p…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）
This document provides an update on a clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk, res…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies [Phase 2]
Phase 2 clinical trial of Ivonescimab in combination with liposomal irinotecan and 5-FU/leucovorin for potentially resectable biliary tract …
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
This clinical trial assesses the diagnostic capacity of extrachromosomal circular DNAs (eccDNAs) as biomarkers for indeterminate biliary str…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
This update notes that the expanded access treatment protocol for Zanidatamab (ZW25) in patients with HER2-positive advanced biliary tract c…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
A clinical trials.gov update notes a recruiting study evaluating on-treatment surveillance of tumor evolution and response to systemic thera…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Domvanalimab and Zimberelimab in Advanced Liver Cancers [Phase 2]
Phase 2 trial update examining domvanalimab and zimberelimab in advanced liver cancers, including cholangiocarcinoma and hepatocellular carc…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma [Phase 2]
Phase 2 trial update evaluating 3D185 as monotherapy in adults with previously treated locally advanced or metastatic cholangiocarcinoma; th…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery [NA]
This clinical trial aims to evaluate high-volume washing of the abdomen during surgery to improve survival in patients with resectable pancr…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Dragon PLC Trial (DRAGON-PLC) [NA]
A registered clinical trial (DRAGON-PLC) sponsored by Maastricht University is currently recruiting for primary liver cancer indications inc…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) [Phase 2]
Phase 2 trial update for a four-drug regimen (gemcitabine, nab-paclitaxel, lenalidomide, and tislelizumab) in advanced unresectable biliary …
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma [Phase 2]
Phase 2 trial update on Cadonilimab in combination with liposomal irinotecan, leucovorin, and 5-fluorouracil for advanced cholangiocarcinoma…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Fatigue and Pancreas and Bile Duct Cancer Study [EARLY_Phase 1]
An early-phase Phase 1 clinical trial studying fatigue in pancreatic cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab with or without capecitabine as adjuvant therapy for biliary tract cancers; th…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Efficacy of Fistulotomy for Biliary Cannulation [NA]
A clinical trial evaluating the efficacy of fistulotomy for biliary cannulation is currently recruiting in Mexico. It studies patients with …
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Liver Cancer Registry Platform
A liver cancer registry platform clinical trial sponsored by iOMEDICO AG is currently recruiting for hepatocellular carcinoma and cholangioc…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma [Phase 2]
A Phase 2 study completed in Asian participants evaluated Erdafitinib, a pan-FGFR tyrosine kinase inhibitor, for efficacy in advanced non-sm…